LCM
IDYA icon

Legato Capital Management’s IDEAYA Biosciences IDYA Stock Holding History

Legato Capital Management’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-32,042
Closed -$1.07M – 765
2026
Q1 		$1.07M Buy
32,042
+8,142
+34% +$273K 0.1% 275
2025
Q4 		$826K Buy
+23,900
New +$762K 0.07% 406
2024
Q3 		– Sell
-9,104
Closed -$320K – 601
2024
Q2 		$320K Sell
9,104
-5,697
-38% -$226K 0.04% 485
2024
Q1 		$649K Buy
14,801
+2,307
+18% +$99.2K 0.08% 378
2023
Q4 		$445K Buy
+12,494
New +$373K 0.06% 437

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Legato Capital Management's IDYA Position: Q2 2026 in Review

Legato Capital Management sold out of IDEAYA Biosciences (IDYA) in Q2 2026, closing a stake of 32,042 shares — an estimated $1.07M sold.

Legato Capital Management first reported a position in IDYA in Q4 2023 and held it in 5 quarters. The position peaked at $1.07M in Q1 2026. 285 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Legato Capital Management reported no remaining IDEAYA Biosciences position as of Q2 2026 after selling out during the quarter.
  • Legato Capital Management sold 32,042 IDEAYA Biosciences shares in Q2 2026, an estimated $1.07M.
  • Legato Capital Management first reported a position in IDEAYA Biosciences in Q4 2023 and held it in 5 quarters.
  • Legato Capital Management's IDEAYA Biosciences position peaked at $1.07M in Q1 2026.
  • 285 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Legato Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.